Behavioral Efficacy of Haloperidol and Lithium Carbonate

摘要: • The efficacy and safety of haloperidol, lithium carbonate, placebo were critically assessed in 61 treatment-resistant, hospitalized children aged 5.2 to 12.9 years with diagnoses conduct disorder, aggressive type. In this double-blind well-controlled study, the optimal dosages haloperidol ranged from 1.0 6.0 mg/day those carbonate 500 2,000 mg/day. For assessment behavioral changes untoward effects, various rating scales used different settings. Both found be significantly superior decreasing symptoms. Although both medications clinically effective, was associated more often effects than carbonate.